Effects of Atorvastatin on Reducing F-FDG Accumulation in Atherosclerotic Plaques: Using PET Imaging Study: pilot phase.
Phase of Trial: Phase II
Latest Information Update: 02 Mar 2013
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atherosclerosis; Hyperlipidaemia
- Focus Pharmacodynamics
- Acronyms EARDROP
- 12 Nov 2010 Status changed from active, no longer recruiting to completed.
- 03 Oct 2009 New trial record